Produção Nacional
Revisado por pares
BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA
2020; Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE); Volume: 57; Issue: suppl 1 Linguagem: Inglês
10.1590/s0004-2803.202000000-20
ISSN1678-4219
AutoresAline Lopes Chagas, Ângelo Alves de Mattos, Flair José Carrilho, Paulo Lisboa Bittencourt, Denise Cerqueira Paranaguá‐Vezozzo, Natally Horvat, Manoel de Souza Rocha, Venâncio Avancini Ferreira Alves, Gabriela Perdomo Coral, Mário Reis Álvares‐da‐Silva, Fábio Marinho do Rego Barros, Marcos Roberto de Menezes, Lucas Moretti Monsignore, Fabrício Ferreira Coelho, Renato Ferreira da Silva, Rita de Cássia Martins Alves da Silva, I.F.S.F. Boin, Luiz Augusto Carneiro D’Albuquerque, José Huygens Parente Garcia, Guilherme Eduardo Gonçalves Felga, Airton Mota Moreira, Maria Ignez Braghiroli, Paulo M. Hoff, Vivianne Mello, Mariana Fonseca Dottori, Tiago Pugliese Branco, Leonardo de Lucca Schiavon, Thaisa de Fatima Almeida Costa,
Tópico(s)Liver Disease and Transplantation
ResumoHepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. The Brazilian Society of Hepatology (SBH) published in 2015 its first recommendations about the management of HCC. Since then, new data have emerged in the literature, prompting the governing board of SBH to sponsor a single-topic meeting in August 2018 in São Paulo. All the invited experts were asked to make a systematic review of the literature reviewing the management of HCC in subjects with cirrhosis. After the meeting, all panelists gathered together for the discussion of the topics and the elaboration of updated recommendations. The text was subsequently submitted for suggestions and approval of all members of the Brazilian Society of Hepatology through its homepage. The present manuscript is the final version of the reviewed manuscript containing the recommendations of SBH.
Referência(s)